Subarachnoid hemorrhage as a complication associated with thrombolysis in a patient with ischemic stroke.
DOI:
https://doi.org/10.20453/rnp.v84i4.4138Keywords:
Stroke, brain ischemia, thrombolytic therapy, subarachnoid hemorrhageAbstract
Subarachnoid hemorrhage is a very rare complication of thrombolytic therapy. We report the case of a 76-year- old mestizo woman with a pacemaker, admitted to the emergency room due to compromised consciousness, walking difficulties and dysarthria. She reported a history of poorly controlled hypertension, hypothyroidism, and numerous surgical interventions. Based on a non-contrast Multislice Computed Tomography (MSCT) of the brain and the clinical manifestations, a diagnosis of ischemic stroke was established. Thrombolytic therapy with alteplase was immediately started and another non-contrast MSCT brain scan, performed three hours later, identified a subarachnoid hemorrhage as a treatment complication. Twenty-four hours later, a CT angiography confirmed an ischaemic stroke with hemorrhagic transformation, without the presence of a ruptured aneurysm. The patient was admitted to ICU, remaining in observation with permanent control of vital signs, and discharged after 20 days. the patient was discharged. The identification and reporting of this unusual complication contribute to a better understanding and diagnosis of the case.
References
Phipps M, Cronin C. Management of acute ischemic stroke. BMJ. 2020;368: l6983. DOI:10.1136/bmj. l6983
Oliveira J, Samuels O. Intravenous thrombolytic therapy for acute ischemic stroke: Therapeutic use. UpToDate. 2020. (Citado el 7 de octubre de 2020). Disponible en: https://www.uptodate.com/contents/ intravenous-thrombolytic-therapy-for-acute- ischemic-stroke-therapeutic-use. DOI: 10.1056/ NEJMct1007370 3. Campbell B, Khatri P. Stroke. The Lancet. 2020; 396 (10244): 129–42. DOI: 10.1016/s0140- 6736(20)31179-x
De Leciñana M, Egido J, Casado I, Ribó M, Dávalos A, Masjuan J, et al. Guía para el tratamiento del infarto cerebral agudo. Neurología. 2014; 29(2): 102-22. DOI: 10.1016/j.nrl.2011.09.012
Powers W, Rabinstein A, Ackerson T, Adeoye O, Bambakidis N, Becker K. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019; 50 (12): e344-e418. DOI: 10.1161/str.0000000000000211
Oliveira J, Mullen MT. Initial assessment and management of acute stroke. UpToDate. 2020. (Citado el 7 de julio de 2021). Disponible en: https://www.uptodate.com/contents/initial- assessment-and-management-of-acute- stroke?topicRef=16134&source=see
Whiteley W, Emberson J, Lees K, Blackwell L, Albers G, et al. Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis. Lancet Neurol. 2016; 15: 925–33. DOI: 10.1016/S1474-4422(16)30076-X
The NINDS T-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke. 1997; 28: 2119- 25. DOI: 10.1161/01.str.28.11.2119
Choi J, Kim J, Han M, Lee S, Kang K, Park J, et al. Utility of Items of Baseline National Institutes of Health Stroke Scale as Predictors of Functional Outcomes at Three Months after Mild Ischemic Stroke. J Stroke Cerebrovasc Dis. 2017; 26 (6): 1306- 13. DOI: 10.1016/j.jstrokecerebrovasdis.2017.01.027.
Moussaddy A, Demchuk A, Hill M. Thrombolytic therapies for ischemic stroke: Triumphs and future challenges. Neuropharmacology. 2018; 134: 272-79. DOI:10.1016/j.neuropharm.2017.11.010
Cheng J, Zhang X, Cheng L, Li G, Zhang L, Ji K, et al. Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta- Analysis. Journal of Stroke and Cerebrovascular Diseases. 2018; 27(2): 381–90. DOI: 10.1016/j. jstrokecerebrovasdis.2017.09.014
Aulicky P, Rabinstein A, Seet R, Neumann J, Mikulik R. Dosing of Tissue Plasminogen Activator Often Differs from 0.9 mg/kg, but Does Not Affect the Outcome. Journal of Stroke and Cerebrovascular Diseases. 2013; 22(8): 1293–97. DOI: 10.1016/j. jstrokecerebrovasdis.2012.10.010
Chou C, Lin Y, Po H, Chang C. Subarachnoid emorrhage: a rare complication after intravenous thrombolysis in an ischemic stroke patient. Am J Emerg Med. 2010; 28 (8): 984. e1-3. DOI: 10.1016/j. ajem.2009.12.024
Lagares A, Gomez P, Lobato R, Alén J, Campollo J, Benito-León J. Cerebral aneurysm rupture after r-TPA thrombolysis for acute myocardial infarction. Surg Neurol. 1999; 52 (6): 623-6. DOI: 10.1016/ s0090-3019(99)00147-0
Gopal M, Lakhani S, Lee VH. Intravenous Thrombolysis in Acute Ischemic Stroke Patients with Unsuspected Infective Endocarditis. J Stroke Cerebrovasc Dis. 2021; 30(3):105502. DOI: 10.1016/j.jstrokecerebrovasdis.2020.105502
Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G. European Stroke Organization Guidelines for the Management of Intracranial Aneurysms and Subarachnoid Haemorrhage. Cerebrovasc Dis. Cerebrovasc Dis. 2013; 35 (2): 93– 112. DOI: 10.1159/000346087
Barinagarrementería F, Dávila L, López M, Orozco A. Neurología elemental. New York: Elsevier Health Sciences; 2017.
Villatoro A. Manual de medicina de urgencias. Ciudad de Mexico: Editorial El Manual Moderno; 2013.
RNP is distributed under a 